Clinical Trials Sponsored by Encore Clinical

Total 19426 results

Xencor, Inc.

Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

United States
Xencor, Inc.

Active, not recruiting

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United States, Canada
Xencor, Inc.

Terminated

Study Evaluating AMG 424 in Subjects With Multiple Myeloma

Relapsed/ Refractory Multiple Myeloma

United States, Australia
Xencor, Inc.

Completed

Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

Allergic Rhinitis | Atopic Dermatitis | Allergic Conjunctivitis

United States
Foundation for Orthopaedic Research and Education
Encore DJO Global

Completed

Prospective, Observational Clinical Investigation of the Exos Reformable Brace (EXOS)

Distal Radius Fracture

United States
Geisinger Clinic
Clinical Innovations

Withdrawn

The Effect of Traxi Panniculus Retractor on Surgical Time at Non-emergent Cesarean Delivery in Obese Women

Obesity

United States
EndoCore Lab s.r.l.

Recruiting

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia (PiPER)

Diabetic Foot | Peripheral Arterial Disease | Critical Limb-Threatening Ischemia

Italy
Vicore Pharma AB

Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Tolerance | Safety Issues

Sweden
Vicore Pharma AB

Completed

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Endothelial Dysfunction | Type2diabetes

Sweden
Ancora Heart, Inc.

Active, not recruiting

Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation (CorCinch-PMVI)

Heart Failure | Cardiomyopathy, Dilated

United States
Vicore Pharma AB

Completed

Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (ATTRACT-2)

Covid19

India
SynCore Biotechnology Co., Ltd.

Terminated

Study of SCB01A in Patient With Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Taiwan
SynCore Biotechnology Co., Ltd.

Terminated

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
SynCore Biotechnology Co., Ltd.

Suspended

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

Triple-Negative Breast Cancer

Taiwan
Xencor, Inc.
ICON plc

Completed

A Study of XmAb®18087 in Subjects With NET and GIST

Neuroendocrine Tumor | Gastrointestinal Neoplasm

United States
Cordis Corporation
Ensure Medical

Completed

Plug Arterial Closure System (PACS, 7F) (PACS 7F)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Mexico
Vicore Pharma AB

Completed

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects (ATTRACT-3)

COVID-19

Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
Ancora Heart, Inc.

Active, not recruiting

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Heart Failure | Mitral Valve Insufficiency | Cardiomyopathies

United States
Ancora Heart, Inc.

Completed

A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study (CINCH-2)

Mitral Regurgitation | Mitral Valve Regurgitation | Functional Mitral Regurgitation

Austria, Lithuania, Germany
Ancora Heart, Inc.

Completed

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function (LVRESTORESA)

Functional Mitral Regurgitation

Colombia
Kitani, Lenore, PT

Completed

Pelvic Floor Activity and Breathing in Women

Respiration | Pelvic Floor

United States
InCor Heart Institute

Recruiting

Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial (SILENT)

Atrial Fibrillation

Brazil
InCor Heart Institute

Completed

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Langerhans Cell Histiocytosis

Brazil
InCor Heart Institute

Completed

IVUS Guidance to Reduce Contrast in Coronary Angioplasty (MOZART)

Acute Renal Failure | Contrast Media Reaction

Brazil
InCor Heart Institute

Unknown

Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy (Mozart-II)

Acute Kidney Injury | Acute Renal Failure | Acute Renal Injury

Brazil, Spain
InCor Heart Institute

Completed

Losartan in Decompensated Heart Failure

Congestive Heart Failure | Low Cardiac Output

Brazil
Tulane University
Louisiana Clinical and Translational Science (LA CaTS) Center Clinical Research...

Completed

Epigenetic Analysis of Regulation of the Inflammasome-activating NLRP3 Gene in Monocytes From Atrial Fibrillation Patients and Controls

Atrial Fibrillation | Arrhythmia

United States
SynCore Biotechnology Co., Ltd.

Completed

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

Pancreatic Adenocarcinoma | Metastatic Pancreas Cancer | Locally Advanced Pancreatic Cancer

United States, Korea, Republic of, Taiwan, France, Hungary, Israel, Russian Federation
Xencor, Inc.
ICON plc

Terminated

Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer

Small Cell Lung Cancer | Merkel Cell Carcinoma

United States
SynCore Biotechnology Co., Ltd.

No longer available

Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

Malignant Solid Tumour
SynCore Biotechnology Co., Ltd.

Completed

A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy

Solid Tumors

Taiwan
Encore Medical Inc.
Bright Research Partners; Yale Cardiovascular Research Group

Recruiting

Encore PFO Closure Device - The PerFOrm Trial

Patent Foramen Ovale | Cryptogenic Stroke

United States
Encore Medical, L.P.
VA Salt Lake City Health Care System

Unknown

Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP) (POP)

Traumatic Amputee

United States
InCor Heart Institute

Recruiting

Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

Coronary Artery Disease | Menopause

Brazil
InCor Heart Institute

Recruiting

The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers (RE-AGES)

Coronary Artery Disease | Menopause | Endothelial Dysfunction

Brazil
InCor Heart Institute

Recruiting

PREemptive Analgesia With preGABAlin in HEART Surgery (PREGABA-HEART)

Postoperative Pain

Brazil
InCor Heart Institute

Unknown

Peripherally Inserted Central Catheter Use for Dobutamine Infusion in Heart Failure Patients (DOBUTAPICC)

Congestive Heart Failure

Brazil
InCor Heart Institute

Unknown

Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction

Hypertension | Heart Failure, Diastolic

Brazil
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects With Advanced Solid Tumors

Solid Tumor

Australia
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH002 in Combination With YH001 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China, Australia
Vicore Pharma AB
Orphan Reach

Completed

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Idiopathic Pulmonary Fibrosis

United Kingdom, India, Ukraine, Russian Federation
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Vicore Pharma AB
Curebase Inc.

Active, not recruiting

Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF (COMPANION)

Generalized Anxiety Disorder | Pulmonary Fibrosis

United States
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Australia
Xencor, Inc.
Massachusetts General Hospital

Completed

Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)

IgG4-RD

United States
Ettore Sansavini Health Science Foundation

Unknown

PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus (PROCIDA)

Tricuspid (Valve) Insufficiency (Rheumatic)

Italy
Ettore Sansavini Health Science Foundation

Unknown

Safety and Feasibility of Electrical Isolation of the Superior Vena Cava for Paroxysmal Atrial Fibrillation (SAFE-SVC)

Paroxysmal Atrial Fibrillation

Italy, Belgium, Netherlands, Russian Federation
Government College of Dentistry, Indore

Completed

To Study the Beneficial Effect of Mustard Oil and Salt Massaging With Oral Prophylaxis in Patients With Gum Diseases

Chronic Periodontitis

India
Government College of Dentistry, Indore

Unknown

Efficacy of AloeVera Gel Gum Massaging and Adjunct to Scaling and Root Planing in Chronic Periodontitis Patients

CHRONIC PERIODONTITIS

Clinical Trials Sponsored by Encore Clinical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations